Eli Lilly and Company (LLY)

Operating return on assets (Operating ROA)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Operating income (ttm)	US$ in thousands	-1,337,200	-1,535,600	-282,100	-575,400	564,300	647,900	1,187,200	881,300	-483,600	139,600	-688,500	-476,400	-138,600	1,226,100	1,652,600	1,613,500	432,200	315,600	-13,300	-82,000
Total assets	US$ in thousands	64,006,300	57,915,500	54,814,000	53,163,000	49,489,800	47,461,500	47,063,600	46,919,300	48,806,000	48,187,000	47,809,000	46,838,300	46,633,100	43,946,000	41,967,000	41,102,800	39,286,100	37,893,100	38,666,400	38,006,800
Operating ROA		-2.09%	-2.65%	-0.51%	-1.08%	1.14%	1.37%	2.52%	1.88%	-0.99%	0.29%	-1.44%	-1.02%	-0.30%	2.79%	3.94%	3.93%	1.10%	0.83%	-0.03%	-0.22%

December 31, 2023 calculation

Operating ROA = Operating income (ttm) ÷ Total assets
= $-1,337,200K ÷ $64,006,300K
= -2.09%

Lilly(Eli) & Co's operating return on assets (operating ROA) has shown some fluctuations over the past eight quarters. The trend indicates relative stability with occasional deviations. The most recent data for Q4 2023 shows an operating ROA of 16.13%, slightly lower than the previous quarter at 16.16%. The highest operating ROA in the given period was observed in Q3 2022 at 18.43%, while the lowest was in Q1 2023 at 13.75%.

Overall, the company's operating ROA has ranged between 13.75% and 18.43% during the period under review. It is important to note that operating ROA measures the efficiency of the company in generating profits from its assets. The fluctuations observed may be due to various factors such as changes in revenue, expenses, asset utilization, or overall operational efficiency.

In analyzing operating ROA, it is crucial to assess the underlying reasons for the fluctuations and determine if they are indicative of sustainable performance or temporary shifts. This metric provides insights into the company's ability to generate profits from its operational activities relative to its asset base. Further investigation and comparison with industry peers may offer additional context to evaluate Lilly(Eli) & Co's operating ROA performance.